These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2411962)

  • 1. [Clinical evaluation of prostate antigen (PA) in prostate cancer].
    Kuriyama M
    Gan No Rinsho; 1985 May; 31(6 Suppl):606-10. PubMed ID: 2411962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
    Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T
    Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
    Shinoda I
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
    Kuriyama M; Wang MC; Lee CL; Killian CS; Papsidero LD; Inaji H; Loor RM; Lin MF; Nishiura T; Slack NH; Murphy GP; Chu TM
    J Natl Cancer Inst; 1982 Jan; 68(1):99-105. PubMed ID: 6172628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostatic specific antigen in the serum in prostatic cancer].
    Fuse H; Akakura K; Akimoto S; Shimazaki J
    Hinyokika Kiyo; 1987 Jul; 33(7):1049-53. PubMed ID: 2446484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T; Okada K; Oishi K; Yoshida O
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostate specific antigen in serum of the patients with prostatic cancer].
    Akimoto S; Akakura K; Fuse H; Shimazaki J
    Hinyokika Kiyo; 1988 Apr; 34(4):636-42. PubMed ID: 2456678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen in prostate cancer.
    Kuriyama M
    Int J Biol Markers; 1986; 1(2):67-76. PubMed ID: 2448397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
    Machida T; Ohishi Y; Wada T; Akimoto S; Shimazaki J; Oda H; Yokoyama M; Tsukada T; Nakayama T; Akiyama A
    Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation].
    Matui A; Yamada T; Sugita O; Yakata M
    Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Purification and determination of human prostate specific antigen in the serum].
    Ogawa Y; Morikawa J; Ohsawa R; Machida T; Miki M; Yanagisawa M
    Radioisotopes; 1984 May; 33(5):273-8. PubMed ID: 6206524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y; Wang MC; Chu TM
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of human prostate-specific antigen in monitoring prostate cancer.
    Kuriyama M; Wang MC; Lee CI; Papsidero LD; Killian CS; Inaji H; Slack NH; Nishiura T; Murphy GP; Chu TM
    Cancer Res; 1981 Oct; 41(10):3874-6. PubMed ID: 7284995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
    Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
    Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.